Mapsplatin 100 Injection
Marketer
AMPS Biotech Pvt Ltd
Salt Composition
Oxaliplatin (100mg)
Overview Mapsplatin 100 Injection
Oncoplatin-100 Injection combats colorectal cancer by inhibiting or retarding cancerous cell proliferation. Administered intravenously by a healthcare professional, dosage and frequency are determined by your physician based on your condition and may vary. Adhere strictly to prescribed instructions; improper usage or overdose can lead to severe adverse effects. Therapeutic benefits may take weeks or months to manifest; discontinue only under medical supervision. Common side effects include nausea, tiredness, vomiting, and diarrhea. The medication can reduce blood cell counts (red and white), increasing infection risk. Severe allergic reactions (e.g., mouth sores, rash, itching, dyspnea) necessitate immediate medical attention. Regular blood tests monitor blood cell counts, as well as heart, liver, and uric acid levels. Inform your doctor of pre-existing heart, liver, or kidney disease, or concurrent use of other medications, particularly anti-infectives. Numerous drug interactions are possible; disclose all medications to your healthcare provider. Use is contraindicated during pregnancy and breastfeeding. Male infertility is a potential side effect; sperm cryopreservation should be considered. Driving is discouraged due to potential dizziness.
Primary Ingredients of Mapsplatin 100 Injection
There is no text provided to rephrase.
Uses of Mapsplatin 100 Injection
Colorectal cancer
Major Benefits of Mapsplatin 100 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Mapsplatin 100 Injection:
- Nausea
- Fatigue
- Anemia (low number of red blood cells)
- Vomiting
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Low blood platelets
- Increased liver enzymes
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Stomatitis (Inflammation of the mouth)
How to use Mapsplatin 100 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Mapsplatin 100 Injection works:
Platinol-100 Injection is a chemotherapeutic agent used in cancer treatment. Its mechanism of action involves disrupting the cellular DNA and RNA of cancerous cells, thus inhibiting their proliferation and growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of alcohol with Mapsplatin 100 Injection is uncertain; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Mapsplatin 100 Injection during pregnancy is contraindicated due to confirmed harm to the fetus. Exceptions may exist in critical circumstances where the physician deems the potential advantages outweigh the inherent risks. Physician consultation is mandatory.
Breast feedingUNSAFE
Administration of Mapsplatin 100 Injection is contraindicated while breastfeeding due to potential infant toxicity.
DrivingUNSAFE
Administering Mapsplatin 100 Injection or undergoing Oxaliplatin therapy might induce adverse reactions, including dizziness, nausea, vomiting, and other neurological issues impacting ambulation. These effects could impair driving ability.
KidneyCAUTION
The administration of Mapsplatin 100 Injection requires careful consideration in individuals with severe renal impairment, potentially necessitating dosage modification. Consult a physician for guidance. Data regarding Mapsplatin 100 Injection use in such patients is limited. Dosage alteration is not advised for those with mild or moderate kidney disease.
LiverCAUTION
Patients with hepatic impairment should receive Mapsplatin 100 Injection with close monitoring. Dosage modification may be necessary. Physician consultation is recommended.
What if you forget to take Mapsplatin 100 Injection :
Should you forget a scheduled Mapsplatin 100 Injection, seek your physician's advice.
Facts to Know About Mapsplatin 100 Injection
| Label | Value |
|---|---|
| Type of Compound | Platinum-based compounds |
| Potential for Dependence | None. |
| Medication Classification | Cancer-fighting drugs |
| Mechanism of Action | Platinum-based anti-neoplastic agents |
3,018 People bought this recently